Divis Laboratories has entered into a long term manufacturing and supply agreement with a global pharma company.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Despite recent corrections, the Piramal Pharma stock has shown remarkable resilience, tripling investor wealth since 2023-24.

Steris plc is a Strong Buy with $281 fair value. Click for why STE, backed by growth, margin expansion & reshoring tailwinds, ...

Sanofi plans to invest $20 billion in U.S.-based drug R&D and manufacturing over five years, creating jobs and boosting ...

The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing ...

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...

A Bengaluru pharmaceutical company has pioneered a technology to remove organic solvents in drug production, enhancing safety ...

Michela Tindera Botox, the anti-wrinkle drug that’s been injected into countless celebrity foreheads. Today, it’s made by a major American pharmaceutical company. And Westport’s just one of many Irish ...

Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is ...